Coming November 4: ASH publishes its abstracts and its oral and poster sessions. We’ll add the institutions presenting them as they become publicly available.

Daiichi Sankyo at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Daiichi Sankyo exhibits at Booth 1939 at ASH 2026 in New Orleans. Daiichi Sankyo supports a symposium on how acute myeloid leukemia is managed today. The program reviews patient cases in the style of a second opinion.

OrganizationASH 2026 Attendance
Daiichi Sankyo
Tokyo, Japan
daiichisankyo.com
Large pharma2 exhibitor meeting rooms
Japanese pharmaceutical company with around 16,000 employees in over 20 countries, whose oncology medicines include antibody-drug conjugates.
Booth
Exhibiting at Booth 1939
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm
Symposium
Fri Dec 11
7:00am–10:00am
Current Management Paradigms in Acute Myeloid Leukemia – A Second Opinion Case Review
Difficult acute myeloid leukemia cases where doctors sought second opinions, paired with reviews of recent data, current management, and ongoing trials.
Sheraton New Orleans · Napoleon Ballroom AB
Leukemias

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Daiichi Sankyo

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction